Decade-Long Outcomes of SAPIEN 3 TAVR vs. Surgery in Intermediate-Risk Aortic Stenosis Patients
intermediate-risklong-term outcomesSAPIEN 3Surgical Aortic Valve ReplacementTranscatheter Aortic Valve Replacement
Highlight
- At 10 years, mortality rates after SAPIEN 3 transcatheter aortic valve replacement (TAVR) and surgical aortic valve replacement (SAVR) in intermediate-risk patients were similar.
- Aortic valve reintervention rates and valve hemodynamics were comparable between TAVR and surgery, demonstrating sustained valve durability through a decade.
- This study highlights the feasibility and challenges of extended follow-up in elderly cohorts, emphasizing the importance of long-term data in guiding treatment selection.
Study Background
MedXY registered readers
Sign in free to continue reading
Create or use your MedXY account to unlock the complete article.
This article was created using several editorial tools, including AI, as part of the process. Human editors reviewed this content before publication.